The Economist has published an article challenging the likelihood of new diet drugs reducing obesity rates, despite their risks. One drug in particular is Qysmia, which contains topiramate, the active ingredient in Topamax. Qysmia has been under review by the Food and Drug Administration (FDA) for more than a year.
Posts Tagged 'Qysmia'
Tags: Qysmia, Qysmia topiramate, Qysmia weight loss, Topamax, Topamax and birth defects, Topamax and pregnancy, Topamax birth defects, Topamax recall, Topamax side effects, Topamax while pregnant, topiramate, topiramate birth defects, topiramate during pregnancy, topiramate side effects, topiramate warning